Analytics

Biologics Quality Control: The Growing Need for Accessible Proteomics

There is a great need for sensitive, precise, and easily accessible analytical detection techniques for protein sequencing.

Emerging Therapies Drive Analytical Advancements

The emergence of mRNA vaccines and cell and gene therapies has pushed innovation in analytical methods.

Analyzing Exabytes

Effective analytics will eliminate failures, deviations, and non-conformances.

Ajinomoto Althea Adds High Potency Capabilities

September 21, 2017

PTSM: Pharmaceutical Technology Sourcing and Management

Ajinomoto Althea opens manufacturing suites in new high potency and antibody drug conjugate commercial facility.

Gates Foundation Invests $40 Million in Immunotherapy Collaboration

September 19, 2017

The collaboration with Immunocore, a T cell receptor company, aims to discover and develop immunotherapy molecules to treat infectious diseases.

FDA Approves Amgen’s Avastin Biosimilar

September 15, 2017

The approval marks the first biosimilar approved in the United States for treating cancers.

EMA Recommends Approval of Herceptin Biosimilar

September 15, 2017

European Medicines Agency’s Committee for Medicinal Products for Human Use grants a positive opinion for the approval of the biosimilar for treating breast cancer.

Sartorius Opens New Manufacturing Facility for Lab Instruments

September 13, 2017

The new building is protected by special construction against vibration to ensure accurate calibration of laboratory balances.

Oxford Genetics Opens First US Office

September 12, 2017

The company has extended its presence in the US market to support its growing business in the region.

Merck KGaA Completes $788-Million Divestment of Biosimilars Business

September 07, 2017

Merck KGaA completes the divestment of its biosimilars business as part of its strategy to focus on developing a pipeline of innovator drugs.

PTSM: Pharmaceutical Technology Sourcing and Management